Chongqing University Cancer Hospital

Chongqing University Cancer Hospital, formerly Chongqing Cancer Hospital, is the main cancer centre for south-west China's largest city and a growing site for domestic trials. It is a municipal cancer centre with more than a thousand beds, holds the regional cancer registry role for Chongqing, takes part in national screening programmes, and enrols patients in registration trials of Chinese PD-1 antibodies, antibody-drug conjugates and kinase inhibitors. Its place in OnCo is as one of the large provincial and municipal centres through which China's domestic drug pipeline reaches patients outside Beijing, Shanghai and Guangzhou. Whether its registry data become publicly usable for research is the question a reader should ask. Its regional centre and clinical trials programmes are listed below.